Volatile Stocks In News: Geron Corporation (NASDAQ:GERN), Aviat Networks Inc. (NASDAQ:AVNW), Life Time Fitness, Provectus Pharmaceuticals Inc., NewLead Holdings

Geron Corporation (NASDAQ:GERN)’s shares gained 4.21% to $2.02. The company on May 9 announced that it has set May 28, 2014 as the record date for the distribution to Geron stockholders of the Series A Common Stock from Asterias Biotherapeutics, Inc. (“Asterias”) that Geron received in the previously announced transaction to divest Geron`s human embryonic stem cell assets, which closed on October 1, 2013. Geron … Continue reading Volatile Stocks In News: Geron Corporation (NASDAQ:GERN), Aviat Networks Inc. (NASDAQ:AVNW), Life Time Fitness, Provectus Pharmaceuticals Inc., NewLead Holdings

Biotech Losers: Insys Therapeutics Inc (NASDAQ:INSY), Enzymotec Ltd (NASDAQ:ENZY), Geron Corporation (NASDAQ:GERN), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Insys Therapeutics, Inc. (NASDAQ:INSY)’s shares have been under pressure recently on news regarding prescribing patterns for Subsys. The stock price of the company tumbled 17.41% and 15.45% in the last two consecutive trading sessions. Insys Therapeutics Inc (NASDAQ:INSY) stock performance was -15.70% in last session and finished the day at $23.01. Traded volume was 3.24million shares in the last session and the average volume of … Continue reading Biotech Losers: Insys Therapeutics Inc (NASDAQ:INSY), Enzymotec Ltd (NASDAQ:ENZY), Geron Corporation (NASDAQ:GERN), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Neuralstem, Inc. (NYSEMKT:CUR) announced that a study published in the peer-reviewed journal, PLOS ONE, showed that ischemic-stroke rats transplanted with Neuralstem Inc. (NYSEMKT:CUR)’s NSI-566 stem cells in the brain experienced functional improvements. Neuralstem, Inc. (NYSEMKT:CUR) stock performance was 3.74% in last session and finished the day at $3.88. Traded volume was 2.54million shares in the last session and the average volume of the stock remained … Continue reading Biotech Most Volatile: Neuralstem (NYSEMKT:CUR), Aegerion Pharmaceuticals (NASDAQ:AEGR), Galena Biopharma Inc (NASDAQ:GALE), Geron Corporation (NASDAQ:GERN)

Toronto-based North American Palladium Ltd (USA) (NYSEMKT:PAL)’s TSX-listed shares on Friday climbed by as much as C$0.09 apiece in early trading after the company announced that it had expanded the reserves and resources at its flagship Lac des Iles (LDI) mine by 24% from last year and that palladium production and operating costs in January and February were ahead of guidance. North American Palladium Ltd … Continue reading Micro-cap Active Stocks: North American Palladium (NYSEMKT:PAL), Geron Corporation (NASDAQ:GERN), Unwired Planet (NASDAQ:UPIP), Forest Oil (NYSE:FST)

Mast Therapeutics Inc (NYSEMKT:MSTX) announced that it has completed its acquisition of Aires Pharmaceuticals, Inc. Aires’ lead product candidate, AIR001, is an intermittently nebulized formulation of nitrite that has orphan drug designation in the U.S. and European Union for the treatment of pulmonary arterial hypertension. Mast Therapeutics Inc (NYSEMKT:MSTX) stock performance was 12.12% in last session and finished the day at $0.828. Traded volume was … Continue reading Biotech Active Stocks: Mast Therapeutics Inc (NYSEMKT:MSTX), Geron Corporation (NASDAQ:GERN), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation (NASDAQ:MNKD) on Feb. 18 reported financial results for the fourth quarter and full year ended December 31, 2013. The net loss applicable to common stockholders for fiscal year 2013 was $(191.5) million, or $(0.64) per share based on 299.6 million weighted average shares outstanding, compared with a net loss applicable to common stockholders of $(169.4) million, or $(0.94) per share based on 180.9 … Continue reading Biotech Most Volatile: MannKind Corporation (NASDAQ:MNKD), Inovio Pharmaceuticals (NYSEMKT:INO), Galena Biopharma (NASDAQ:GALE), Geron Corporation (NASDAQ:GERN)